Savient Pharmaceuticals Rising On Takeover Rumor (SVNT)

Shares of Savient Pharmaceuticals Inc SVNT just popped on rumors it could be the subject of a takeover rumor. At this time, it is not known who the potential acquirer could be, but a Reuters article posted yesterday indicated that Abbott ABT, Pfizer PFE or Amgen AMGN could be potential suitors. Shares of SVNT are up 58 cents to $20.86, a gain of 2.86%. Savient is a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States.